Home
About Us
FAQ
Contact Us
Media Tools
ExpertConnect App
MyExpertNet
University Partners
Becoming a Partner
Key Organizations
Search Assistance
Help
Expert Profile
Views:
168
Share
QR code
Edit Profile
Marie-Carmelle Elie
Clinical Associate Professor
MD-EMERGENCY MED-CLINICAL | COLLEGE-MEDICINE
View:
Select
All (all in one)
Research Terms and Keywords
Publications
Network
Websites
Contact
All
Research
Publications
Network
Websites
Contact
Research Terms & Keywords
Research Terms
Medical Sciences
Industries
Health Care
Research Projects
Ends
Title
11-2023
Emergency Medicine-Initiated Palliative Care In Older Adults (EMPallA)
Emergency Medicine-Initiated Palliative Care In Older Adults (EMPallA)
NEW YORK UNIVERSITY SCHOOL OF MEDICIN
11-2023
Emergency Medicine-Initiated Palliative Care In Older Adults (EMPallA)
Emergency Medicine-Initiated Palliative Care In Older Adults (EMPallA)
PATIENTCENTERED OUTCOMES RES INST
06-2023
Primary Palliative Care for Emergency Medicine
Primary Palliative Care for Emergency Medicine
NATL INST OF HLTH NCCA
06-2023
Primary Palliative Care for Emergency Medicine
Primary Palliative Care for Emergency Medicine
NEW YORK UNIVERSITY SCHOOL OF MEDICIN
04-2022
VITAS - Education - Primary Palliative Care for Emergency Medicine
VITAS - Education - Primary Palliative Care for Emergency Medicine
MISCELLANEOUS DONOR
04-2022
CLOVERS: Crystalloid Liberal or Vasopressors Early Resuscitation in Sepsis
CLOVERS: Crystalloid Liberal or Vasopressors Early Resuscitation in Sepsis
BAYSTATE MEDICAL CENTER
04-2022
CLOVERS: Crystalloid Liberal or Vasopressors Early Resuscitation in Sepsis
CLOVERS: Crystalloid Liberal or Vasopressors Early Resuscitation in Sepsis
NATL INST OF HLTH NHLB
08-2021
ARREST RESPIRATORY FAILURE DUE TO PNEUMONIA (ARREST PNEUMONIA)
ARREST RESPIRATORY FAILURE DUE TO PNEUMONIA (ARREST PNEUMONIA)
NATL INST OF HLTH NHLB
08-2021
ARREST RESPIRATORY FAILURE DUE TO PNEUMONIA (ARREST PNEUMONIA)
ARREST RESPIRATORY FAILURE DUE TO PNEUMONIA (ARREST PNEUMONIA)
STANFORD UNI
08-2021
A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults
A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults
LEIDOS
08-2021
A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults
A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults
NATL INST OF HLTH NIAI
04-2021
Acute Lung Injury Group New England Program to Support PETAL Network Research (PETAL Core)
Acute Lung Injury Group New England Program to Support PETAL Network Research (PETAL Core)
BAYSTATE MEDICAL CENTER
04-2021
Acute Lung Injury Group New England Program to Support PETAL Network Research (PETAL Core)
Acute Lung Injury Group New England Program to Support PETAL Network Research (PETAL Core)
NATL INST OF HLTH NHLB
08-2020
Passive Immunity Trial for Our Neighbors (PassItOn): A randomized, placebocontrolled multi-site trial of anti-SARS-CoV-2 convalescent plasma to treat hospitalized adults with COVID-19
Passive Immunity Trial for Our Neighbors (PassItOn): A randomized, placebocontrolled multi-site trial of anti-SARS-CoV-2 convalescent plasma to treat hospitalized adults with COVID-19
NATL INST OF HLTH NCATS
07-2020
Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease (ORCHID)
Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease (ORCHID)
BAYSTATE MEDICAL CENTER
07-2020
Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease (ORCHID)
Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease (ORCHID)
NATL INST OF HLTH NHLB
06-2019
a randomized double blind phase 3 study comparing the efficacy and safety of high titer versus low titer anti influenza immune plasma for the treatment of severe influenza
a randomized double blind phase 3 study comparing the efficacy and safety of high titer versus low titer anti influenza immune plasma for the treatment of severe influenza
NATL INST OF HLTH NIAI
06-2019
a randomized double blind phase 3 study comparing the efficacy and safety of high titer versus low titer anti influenza immune plasma for the treatment of severe influenza
a randomized double blind phase 3 study comparing the efficacy and safety of high titer versus low titer anti influenza immune plasma for the treatment of severe influenza
SOCIAL AND SCIENTIFIC SYSTEM
09-2018
A Randomized Double-Blind Study Comparing Oseltamivir versus Placebo for the Treatment of Influenza in Low Risk Adults
A Randomized Double-Blind Study Comparing Oseltamivir versus Placebo for the Treatment of Influenza in Low Risk Adults
NATL INST OF HLTH NIAI
09-2018
A Randomized Double-Blind Study Comparing Oseltamivir versus Placebo for the Treatment of Influenza in Low Risk Adults
A Randomized Double-Blind Study Comparing Oseltamivir versus Placebo for the Treatment of Influenza in Low Risk Adults
SOCIAL AND SCIENTIFIC SYSTEM
06-2017
Biomarkers of Pediatric Severe Sepsis
Biomarkers of Pediatric Severe Sepsis
FL CLINICAL PRACTICE ASS
01-2017
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Study Evaluating the Safety and Efficacy of Icatibant as a Treatment for Angiotensin-Converting Enzyme (ACE) Inhibitor-Induced Angioedema in Adults
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Study Evaluating the Safety and Efficacy of Icatibant as a Treatment for Angiotensin-Converting Enzyme (ACE) Inhibitor-Induced Angioedema in Adults
SHIRE PHARMACEUTICAL DE
09-2016
A RANDOMIZED DOUBLE BLIND PHASE 2 STUDY COMPARING THE EFFICACY, SAFETY, AND TOLERABILITY OF COMBINATION ANTIVIRALS (Amantadine, Ribavirin,Oseltamivir) versus Oseltamivir for the Treatment of Influenza
A RANDOMIZED DOUBLE BLIND PHASE 2 STUDY COMPARING THE EFFICACY, SAFETY, AND TOLERABILITY OF COMBINATION ANTIVIRALS (Amantadine, Ribavirin,Oseltamivir) versus Oseltamivir for the Treatment of Influenza
NATL INST OF HLTH NIAI
09-2016
A RANDOMIZED DOUBLE BLIND PHASE 2 STUDY COMPARING THE EFFICACY, SAFETY, AND TOLERABILITY OF COMBINATION ANTIVIRALS (Amantadine, Ribavirin,Oseltamivir) versus Oseltamivir for the Treatment of Influenza
A RANDOMIZED DOUBLE BLIND PHASE 2 STUDY COMPARING THE EFFICACY, SAFETY, AND TOLERABILITY OF COMBINATION ANTIVIRALS (Amantadine, Ribavirin,Oseltamivir) versus Oseltamivir for the Treatment of Influenza
SOCIAL AND SCIENTIFIC SYSTEM
06-2016
A Randomized Open-Label, Phase 2, Multicenter Safety and Exploratory Efficacy Study of Investigational anti-Influenza Immune Plasma for the Treatment of Influenza
A Randomized Open-Label, Phase 2, Multicenter Safety and Exploratory Efficacy Study of Investigational anti-Influenza Immune Plasma for the Treatment of Influenza
NATL INST OF HLTH NIAI
06-2016
A Randomized Open-Label, Phase 2, Multicenter Safety and Exploratory Efficacy Study of Investigational anti-Influenza Immune Plasma for the Treatment of Influenza
A Randomized Open-Label, Phase 2, Multicenter Safety and Exploratory Efficacy Study of Investigational anti-Influenza Immune Plasma for the Treatment of Influenza
SOCIAL AND SCIENTIFIC SYSTEM
02-2016
Lung Injury Prevention Study with Aspirin
Lung Injury Prevention Study with Aspirin
MAYO CLINI
10-2015
Influenza Studies IRC003 and IRC004 Domestic Operations
Influenza Studies IRC003 and IRC004 Domestic Operations
LEIDOS
10-2015
Influenza Studies IRC003 and IRC004 Domestic Operations
Influenza Studies IRC003 and IRC004 Domestic Operations
SOCIAL AND SCIENTIFIC SYSTEM
10-2015
Elie NIAID IRC003
Elie NIAID IRC003
SOCIAL AND SCIENTIFIC SYSTEM
03-2015
A Randomized, Open-Label, Phase 2, Multicenter Safety an
A Randomized, Open-Label, Phase 2, Multicenter Safety an
SOCIAL AND SCIENTIFIC SYSTEM
03-2015
A Randomized, Open-Label, Phase 2, Multicenter Safety an
A Randomized, Open-Label, Phase 2, Multicenter Safety an
SOCIAL AND SCIENTIFIC SYSTEM
Publications
OpenAlex
Search Engines
Last updated on 7/25/25. See our
OpenAlex FAQ
for more about this data.
Search Google Scholar for Marie-Carmelle Elie
OpenAlex Works Search
Co-Investigator Network
Nicole Iovine
Clinical Professor, Hospital Epidemiologist and Interim Chair Of Radiation Oncology, Gainesville
University of Florida
Md-Infectious Diseases, College-Medicine
nicole.iovine@medicine.ufl.edu
Sheri Kittelson
Professor, Palliative Care; Chief, Division Of Palliative CARE Department Of Medicine
University of Florida
Md-Palliative CARE Division, College-Medicine
skitte@ufl.edu
Inactive Expert
Rosemarie Fernandez
Clinical Professor; Executive Vice Chair Of Academic Affairs and Faculty Development
University of Florida
Eg-Industrial - Systems Eng, College-Engineering
Torben Becker
Associate Professor & Vice-Chair - Emergency Medicine, Executive Director - Critical CARE Organization
University of Florida
Md-Emergency Med-Aed, College-Medicine
t.becker@ufl.edu
Inactive Expert
Carolyn Holland
Clinical Associate Professor, Medical Director - Pediatric Emergency Department, Division Chief - Pediatric Emergency Medicine
University of Florida
Md-Pediatrics, College-Medicine
Websites
OpenAlex Works Search
Search Google Scholar for Marie-Carmelle Elie
Contact Information
elie@ufl.edu
352-265-5911
1329 GAINESVILLE, FL 32606
Profile QR code
What is this?
Keyword Search
Please enter valid search criteria.
Search
Centers
Experts
Projects
Publications
Speakers
Stories
Technologies
Videos
University
All Universities
Florida A&M University
Florida Atlantic University
Florida Gulf Coast University
Florida Institute of Technology
Florida International University
Florida State University
University of Central Florida
University of Florida
University of Miami
University of North Florida
University of South Florida
University of West Florida
Browse by STEM
Biotechnology
Computer Science
Energy
Engineering
Environmental Sciences
Information Science
Life Sciences
Mathematics
Medical Sciences
Military Sciences
Natural Sciences
Physical Sciences
Plant Sciences
Science
Space Sciences
Technology
Transportation
